Sciele Pharma to Present at the Goldman Sachs 29th Annual Global Healthcare Conference

ATLANTA--(Business Wire)--
Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical
company, today announced that Ed Schutter, President and Chief
Operating Officer, will make a presentation at the Goldman Sachs 29th
Annual Global Healthcare Conference at the Ritz-Carlton Laguna Niguel
in Dana Point, California on Wednesday, June 11, at 9:20 a.m. Pacific
time (12:20 p.m. Eastern time).

The audio presentation is being broadcast on the Internet and may
be accessed at the Company's website, www.sciele.com.

Sciele Pharma, Inc. Background

Sciele Pharma, Inc. is a pharmaceutical company specializing in
sales, marketing and development of branded prescription products
focused on Cardiovascular, Diabetes, Women's Health and Pediatrics.
The Company's Cardiovascular and Diabetes products treat patients with
high cholesterol, hypertension, high triglycerides, unstable angina
and Type 2 diabetes; its Women's Health products are designed to
improve the health and well-being of women and mothers and their
babies; and its Pediatrics products treat allergies, asthma, coughs
and colds, and attention deficit and hyperactivity disorder (ADHD).
Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma
employs more than 900 people. The Company's success is based on
placing the needs of patients first, improving health and quality of
life, and implementing its business platform - an Entrepreneurial
Spirit, Innovation, Execution Excellence, Simplicity, and Teamwork.

Sciele Pharma, Inc.
Joseph T. Schepers, 678-341-1401
Director of Investor Relations
ir@sciele.com

Copyright Business Wire 2008